Boundless Bio, Inc.
BOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $23 | $34 | $49 |
| - Cash | $15 | $15 | $15 | $27 |
| + Debt | $47 | $50 | $49 | $48 |
| Enterprise Value | – | $57 | $67 | $70 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14 | -$15 | -$17 | -$18 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$16 | -$16 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.62 | -0.7 | -0.71 | -0.84 |
| % Growth | 11.4% | 1.4% | 15.5% | – |
| Operating Cash Flow | -$10 | -$12 | -$15 | -$16 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$12 | -$15 | -$16 |